• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于苯并噻吩的异羟肟酸作为高效且选择性的组蛋白去乙酰化酶6(HDAC6)抑制剂的合成。

Synthesis of benzothiophene-based hydroxamic acids as potent and selective HDAC6 inhibitors.

作者信息

De Vreese Rob, Van Steen Nicholas, Verhaeghe Tom, Desmet Tom, Bougarne Nadia, De Bosscher Karolien, Benoy Veronick, Haeck Wanda, Van Den Bosch Ludo, D'hooghe Matthias

机构信息

SynBioC Research Group, Department of Sustainable Organic Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, B-9000 Ghent, Belgium.

出版信息

Chem Commun (Camb). 2015 Jun 18;51(48):9868-71. doi: 10.1039/c5cc03295d.

DOI:10.1039/c5cc03295d
PMID:25994553
Abstract

A small library of 3-[(4-hydroxycarbamoylphenyl)aminomethyl]benzothiophenes was prepared and assessed as a novel class of HDAC6 inhibitors, leading to the identification of three representatives as potent and selective HDAC6 inhibitors. Further tests with regard to inflammatory responses indicated that HDAC6 inhibition can be uncoupled from transcriptional inhibition at the level of activated NF-κB, AP-1, and GR.

摘要

制备了一个由3-[(4-羟基氨基甲酰基苯基)氨甲基]苯并噻吩组成的小型文库,并将其作为一类新型的组蛋白去乙酰化酶6(HDAC6)抑制剂进行评估,从而鉴定出三种具有强效和选择性的HDAC6抑制剂代表物。关于炎症反应的进一步测试表明,在活化的核因子κB(NF-κB)、活化蛋白-1(AP-1)和糖皮质激素受体(GR)水平上,HDAC6抑制作用可以与转录抑制作用解偶联。

相似文献

1
Synthesis of benzothiophene-based hydroxamic acids as potent and selective HDAC6 inhibitors.基于苯并噻吩的异羟肟酸作为高效且选择性的组蛋白去乙酰化酶6(HDAC6)抑制剂的合成。
Chem Commun (Camb). 2015 Jun 18;51(48):9868-71. doi: 10.1039/c5cc03295d.
2
New aryldithiolethione derivatives as potent histone deacetylase inhibitors.新型芳基二硫代烯酮衍生物作为有效的组蛋白去乙酰化酶抑制剂。
Bioorg Med Chem. 2010 Jun 15;18(12):4187-94. doi: 10.1016/j.bmc.2010.05.011. Epub 2010 May 7.
3
Benzofused hydroxamic acids: useful fragments for the preparation of histone deacetylase inhibitors. Part 2: 7-fluorobenzothiophenes and benzofurans.苯并稠合异羟肟酸:用于制备组蛋白脱乙酰酶抑制剂的有用片段。第2部分:7-氟苯并噻吩和苯并呋喃。
Bioorg Med Chem Lett. 2015 Apr 1;25(7):1603-6. doi: 10.1016/j.bmcl.2015.02.007. Epub 2015 Feb 24.
4
Potent and selective inhibition of histone deacetylase 6 (HDAC6) does not require a surface-binding motif.强效且选择性的组蛋白去乙酰化酶 6(HDAC6)抑制剂不需要表面结合基序。
J Med Chem. 2013 Feb 28;56(4):1772-6. doi: 10.1021/jm301355j. Epub 2013 Feb 18.
5
Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors.恶唑异羟肟酸酯作为高选择性组蛋白去乙酰化酶6(HDAC6)抑制剂的合成及生物学研究
J Med Chem. 2016 Feb 25;59(4):1545-55. doi: 10.1021/acs.jmedchem.5b01493. Epub 2015 Dec 22.
6
Discovery of the first histone deacetylase 6/8 dual inhibitors.发现首个组蛋白去乙酰化酶 6/8 双重抑制剂。
J Med Chem. 2013 Jun 13;56(11):4816-20. doi: 10.1021/jm400390r. Epub 2013 May 29.
7
Synthesis and SAR assessment of novel Tubathian analogs in the pursuit of potent and selective HDAC6 inhibitors.新型Tubathian类似物的合成及构效关系评估以寻求高效且具选择性的组蛋白去乙酰化酶6(HDAC6)抑制剂
Org Biomol Chem. 2016 Feb 28;14(8):2537-49. doi: 10.1039/c5ob02625c.
8
Benzofused hydroxamic acids: useful fragments for the preparation of histone deacetylase inhibitors. Part 1: hit identification.苯并稠合羟肟酸:用于制备组蛋白去乙酰化酶抑制剂的有用片段。第 1 部分:命中鉴定。
Bioorg Med Chem Lett. 2013 Jul 15;23(14):4091-5. doi: 10.1016/j.bmcl.2013.05.053. Epub 2013 May 25.
9
Design and synthesis of aryl ether and sulfone hydroxamic acids as potent histone deacetylase (HDAC) inhibitors.芳基醚和砜羟肟酸的设计与合成作为有效的组蛋白去乙酰化酶(HDAC)抑制剂。
Bioorg Med Chem Lett. 2011 Jan 1;21(1):324-8. doi: 10.1016/j.bmcl.2010.11.006. Epub 2010 Nov 5.
10
Potent histone deacetylase inhibitors derived from 4-(aminomethyl)-N-hydroxybenzamide with high selectivity for the HDAC6 isoform.强效组蛋白去乙酰化酶抑制剂来源于 4-(氨甲基)-N-羟基苯甲酰胺,对 HDAC6 同工酶具有高选择性。
J Med Chem. 2013 Sep 26;56(18):7201-11. doi: 10.1021/jm400385r. Epub 2013 Sep 4.

引用本文的文献

1
Identification of Benzothiophene-Derived Inhibitors of Flaviviruses by Targeting RNA-Dependent RNA Polymerase.通过靶向RNA依赖性RNA聚合酶鉴定苯并噻吩衍生的黄病毒抑制剂。
Viruses. 2025 Jan 23;17(2):145. doi: 10.3390/v17020145.
2
A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019).针对神经退行性疾病的组蛋白去乙酰化酶 6 抑制剂的专利审查(2014-2019 年)。
Expert Opin Ther Pat. 2020 Feb;30(2):121-136. doi: 10.1080/13543776.2019.1708901. Epub 2019 Dec 25.
3
HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease.
HDAC6 是突变 GARS 诱导的遗传性运动感觉神经病的治疗靶点。
Brain. 2018 Mar 1;141(3):673-687. doi: 10.1093/brain/awx375.
4
Glucocorticoid Receptor-mediated transactivation is hampered by Striatin-3, a novel interaction partner of the receptor.糖皮质激素受体介导的反式激活受到 Striatin-3 的阻碍,Striatin-3 是受体的一个新的相互作用伙伴。
Sci Rep. 2017 Aug 21;7(1):8941. doi: 10.1038/s41598-017-09246-6.
5
Exploration of thiaheterocyclic hHDAC6 inhibitors as potential antiplasmodial agents.噻唑并杂环 hHDAC6 抑制剂的探索作为潜在的抗疟药物。
Future Med Chem. 2017 Mar;9(4):357-364. doi: 10.4155/fmc-2016-0215. Epub 2017 Mar 6.
6
Design, synthesis and evaluation of antiproliferative activity of melanoma-targeted histone deacetylase inhibitors.黑色素瘤靶向组蛋白去乙酰化酶抑制剂的抗增殖活性的设计、合成与评价
Bioorg Med Chem Lett. 2017 Feb 15;27(4):744-749. doi: 10.1016/j.bmcl.2017.01.044. Epub 2017 Jan 17.
7
Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot-Marie-Tooth Disease.开发改良的HDAC6抑制剂作为轴索性夏科-马里-图斯病的药物治疗方法。
Neurotherapeutics. 2017 Apr;14(2):417-428. doi: 10.1007/s13311-016-0501-z.
8
Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors--What Some May Have Forgotten or Would Rather Forget?为何异羟肟酸酯可能并非最佳的组蛋白去乙酰化酶抑制剂——有些人可能遗忘或宁愿忘却的是什么?
ChemMedChem. 2016 Jan 5;11(1):15-21. doi: 10.1002/cmdc.201500486. Epub 2015 Nov 25.